Xu-sheng Wang, Ph.D. - Publications

2006 Hong Kong University of Science and Technology (Hong Kong) 
Mechanical Engineering

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang XX, Wu YH, Zhang TY, Xu XQ, Dao GH, Hu HY. Simultaneous nitrogen, phosphorous, and hardness removal from reverse osmosis concentrate by microalgae cultivation. Water Research. 94: 215-224. PMID 26954575 DOI: 10.1016/j.watres.2016.02.062  0.36
2015 Wang XJ, Hu W, Zhang TY, Mao YY, Liu NN, Wang SQ. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. Antiviral Research. 120: 140-6. PMID 26086883 DOI: 10.1016/j.antiviral.2015.06.007  0.36
2015 Guo XJ, Ye XF, Wang XX, Wang J, Shi WT, Gao QB, Zhang TY, Xu JF, Zhu TT, He J. Reporting patterns of adverse drug reactions over recent years in China: analysis from publications. Expert Opinion On Drug Safety. 14: 191-8. PMID 25560528 DOI: 10.1517/14740338.2015.985647  0.36
2015 Hu W, Huang H, Zhang TY, Mao YY, Wang XJ, Wang SQ. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model. Antiviral Therapy. 20: 289-95. PMID 25279542 DOI: 10.3851/IMP2870  0.36
2014 Wang XJ, Zhang XJ, Hu W, Zhang TY, Wang SQ. A simple and efficient strategy for the de novo construction of greater-than-genome-length hepatitis B virus replicons. Journal of Virological Methods. 207: 158-62. PMID 25025817 DOI: 10.1016/j.jviromet.2014.07.009  0.36
Show low-probability matches.